EP4316463A1 — Novel formulation
Assigned to GlaxoSmithKline Intellectual Property Development Ltd · Expires 2024-02-07 · 2y expired
What this patent protects
An oral formulation of granules of active pharmaceutical ingredient(s) which disperse rapidly in water are presented. The granules generate a palatable oral suspension in solution with good mouthfeel and are particularly useful for the paediatric or hard-of-swallowing patient pop…
USPTO Abstract
An oral formulation of granules of active pharmaceutical ingredient(s) which disperse rapidly in water are presented. The granules generate a palatable oral suspension in solution with good mouthfeel and are particularly useful for the paediatric or hard-of-swallowing patient population.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.